Results 221 to 230 of about 19,533 (291)
Some of the next articles are maybe not open access.
Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia
Journal of Dermatological Treatment, 2022Background Androgenetic alopecia (AGA) is the most common cause of hair loss, often challenging to treat. While oral finasteride (1 mg/d) is an FDA-approved treatment for male AGA, oral minoxidil and oral dutasteride are not approved yet.
Aditya Gupta
exaly +2 more sources
Minoxidil: a comprehensive review
Journal of dermatological treatment (Print), 2021Topical minoxidil (5% foam, 5% solution, and 2% solution) is FDA-approved for androgenetic alopecia (AGA) in men and women. Mechanism of action: Minoxidil acts through multiple pathways (vasodilator, anti-inflammatory agent, inducer of the Wnt/β-catenin ...
A. Gupta +3 more
semanticscholar +1 more source
Low-Dose Oral Minoxidil for Alopecia: A Comprehensive Review
Skin Appendage Disorders, 2023Low-dose oral minoxidil (LDOM) has demonstrated a promising safety and efficacy profile in the treatment of various hair disorders, including male androgenetic alopecia (AGA) and female-pattern hair loss (FPHL); however, it lacks FDA approval.
Aditya K. Gupta +4 more
semanticscholar +1 more source
Annals of Internal Medicine, 1981
Minoxidil is an orally active vasodilator for treatment of severe hypertension. In combination with diuretics and beta-adrenergic blocking agents, it is effective treatment for more than 80% of patients whose blood pressure has been inadequately controlled with combinations of other been inadequately controlled with combinations of other ...
S L, Linas, A S, Nies
openaire +2 more sources
Minoxidil is an orally active vasodilator for treatment of severe hypertension. In combination with diuretics and beta-adrenergic blocking agents, it is effective treatment for more than 80% of patients whose blood pressure has been inadequately controlled with combinations of other been inadequately controlled with combinations of other ...
S L, Linas, A S, Nies
openaire +2 more sources
Dermatologic Clinics, 1987
Topical minoxidil has shown some promise for the treatment of male-pattern alopecia and alopecia areata. Clinical trials suggest that careful patient selection and appropriate drug formulation are both important factors to maximize efficacy. Side effects attributable to topical minoxidil appear to consist almost entirely of cutaneous reactions in ...
openaire +3 more sources
Topical minoxidil has shown some promise for the treatment of male-pattern alopecia and alopecia areata. Clinical trials suggest that careful patient selection and appropriate drug formulation are both important factors to maximize efficacy. Side effects attributable to topical minoxidil appear to consist almost entirely of cutaneous reactions in ...
openaire +3 more sources
Chest, 1993
A 52-year-old man ingested 60 ml of 2 percent topical minoxidil solution resulting in severe hypotension and tachycardia. He was resuscitated with intravenously administered crystalloid solution and treated with intravenously administered dopamine, resulting in a partial hemodynamic improvement.
A R, MacMillan +2 more
openaire +2 more sources
A 52-year-old man ingested 60 ml of 2 percent topical minoxidil solution resulting in severe hypotension and tachycardia. He was resuscitated with intravenously administered crystalloid solution and treated with intravenously administered dopamine, resulting in a partial hemodynamic improvement.
A R, MacMillan +2 more
openaire +2 more sources
Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose
Journal of the European Academy of Dermatology and Venereology, 2021Topical minoxidil has been used for many years as treatment for different hair disorders. Even though it is an effective therapy, many patients show poor compliance due to the cosmesis, cost and side‐effects.
Alessia Villani +2 more
exaly +2 more sources
Skin Appendage Disorders, 2023
Background: Combination treatments may improve the utility of approved agents for the treatment of pattern hair loss (PHL); however, head-to-head comparisons are lacking.
Aditya K. Gupta +4 more
semanticscholar +1 more source
Background: Combination treatments may improve the utility of approved agents for the treatment of pattern hair loss (PHL); however, head-to-head comparisons are lacking.
Aditya K. Gupta +4 more
semanticscholar +1 more source